评价罗哌卡因复合苏芬太尼在混合痔手术麻醉中的应用

发布时间：2018-12-30 22:05

【摘要】：目的对罗哌卡因与苏芬太尼联合用于混合痔术中麻醉的效果加以探讨。方法选取2014年11月~2015年12月我院收治的混合痔患者96例,将之随机分成观察组与对照组各48例。其中,对照组予单纯以罗哌卡因骶管进行术中麻醉,观察组则予以罗哌卡因与苏芬太尼联合骶管行手术麻醉,对2组患者麻醉起效时间、术后VAS评分及不良反应发生率等加以对比。结果本研究观察组患者在阻滞起效时间、术后手术位置疼痛发作时间、术后VAS评分最高值方面相比于对照组有显著优势,对比差异有统计学意义(t=7.066,8.306,14.012,P0.05);观察组、对照组不良反应发生率分别为20.8%与25.0,对比差异无统计学意义(P0.05);但观察组患者镇痛药使用例数为8例(16.7%),显著少于对照组的19例(39.6%),对比差异有统计学意义(x~2=0.236,6.235,P0.05)。结论以罗哌卡因联合苏芬太尼应用于混合痔患者术中麻醉可有效提高麻醉效果,且可降低不良反应发生率,疗效良好且安全可靠,故可于临床中推广应用。
[Abstract]:Objective to investigate the effect of ropivacaine combined with sufentanil on mixed hemorrhoids. Methods 96 cases of mixed hemorrhoids from November 2014 to December 2015 were randomly divided into two groups: observation group (n = 48) and control group (n = 48). The control group was anesthetized by ropivacaine sacral canal alone, while the observation group was given ropivacaine and sufentanil combined with sacral canal anesthesia. Postoperative VAS score and incidence of adverse reactions were compared. Results compared with the control group, there were significant differences in the onset time of block, the time of postoperative pain attack and the highest value of postoperative VAS score in the study group compared with the control group (t = 7.066, 8.306, 14.012, P0.05). In the observation group, the incidence of adverse reactions in the control group was 20.8% and 25.0 respectively, the difference was not statistically significant (P0.05). But the number of analgesics used in the observation group was 8 cases (16.7%), which was significantly lower than that in the control group (19 cases (39.6%), and the difference was statistically significant (P 0.05). Conclusion ropivacaine combined with sufentanil can effectively improve the anesthetic effect and reduce the incidence of adverse reactions in patients with mixed hemorrhoids, so it can be popularized in clinical practice.
【作者单位】：河北省献县中医医院麻醉科;
【分类号】：R614

【参考文献】